Molecular Markers in Stored Kidneys Using Perfluorocarbon-based Preservation Solution: Preliminary Results

Transplantation Proceedings

Volumn 38, Issue 5, 2006, Pages 1243-1246

  Maluf, D G ^a   Mas, V R ^a,b   Yanek, K ^a   Stone, J J ^a   Weis, R ^a,b   Massey, D ^b   Spiess, B ^a,b   Posner, M P ^a   Fisher, R A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUOROCARBON; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PRESERVATION SOLUTION; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOLOGY; ISCHEMIA; KIDNEY; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAT; STORAGE TEMPERATURE;

ADENOSINE; ALLOPURINOL; ANIMALS; BIOLOGICAL MARKERS; FLUOROCARBONS; GENE EXPRESSION REGULATION; GLUTATHIONE; HEME OXYGENASE-1; INSULIN; KIDNEY; MALE; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE II; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; RATS; RATS, INBRED ACI; RNA, MESSENGER;

EID: 33745210738     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.02.109     Document Type: Article

References (19)

1. Koning O.H., Ploeg R.J., van Bockel J.H., et al. Risk factors for delayed graft function in cadaveric kidney transplantation. a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 63 (1997) 1620
2. Ojo A.O., Wolfe R.A., Held P.J., et al. Delayed graft function. risk factors and implications for renal allograft survival. Transplantation 63 (1997) 968
3. Matas A.J., Gillingham K.J., Humar A., et al. Immunologic and nonimmunologic factors. different risks for cadaver and living donor transplantation. Transplantation 69 (2000) 54
4. Kacar S., Gurkan A., Varilsuha C., et al. Marginal donors in kidney transplantation. Ann Transplant 9 (2004) 5
5. Vedder N.B., Winn R.K., Rice C.L., et al. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci U S A 87 (1990) 2643
6. Takada M., Nadeau K.C., Shaw G.D., et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. inhibition by a soluble P-selectin ligand. J Clin Invest 99 (1997) 2682
7. Herskowitz A., Choi S., Ansari A.A., et al. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146 (1995) 419
8. Otterbein L., and Choi A.M.K. Heme oxygenase. colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1029
9. Agarwal A., and Nick H.S. Renal response to tissue injury. lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol 11 (2000) 965
10. Maines M.D. The heme oxygenase system. a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37 (1997) 517
11. Gage F.A., and Vodovotz Y. Normalization of nitric oxide flux improves physiological parameters of porcine kidneys maintained on pulsatile perfusion. Nitric Oxide 9 (2003) 141
12. Shorr R.G. IBC's 5th annual conference on blood substitutes. Expert Opin Investig Drugs 7 (1998) 283
13. 2) method of pancreas preservation before transplantation. Transplantation 70 (2000) 771
14. Iwanaga Y., Suzuki Y., Okada Y., et al. Ultrastructural analyses of pancreatic grafts preserved by the two-layer cold-storage method and by simple cold storage in University of Wisconsin solution. Transpl Int 15 (2002) 425
15. Keitaro K., Yasuhiro F., Yasuyuki S., et al. Protection against ischemia/reperfusion injury by the cavitary two-layer method in canine small intestinal transplantation with reduction of reactive oxygen species. Surgery 135 (2004) 642
16. DeRoover A., Krafft M.P., Deby-Dupont G., et al. Seventy-two hours hypothermic intestinal preservation study using a new perfluorocarbon emulsion. Artif Cells Blood Substit Immobil Biotechnol 29 (2001) 225
17. Cheng P.Y., Chen J.J., and Yen M.H. The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats. Am J Hypertens 17 (2004) 1127
18. Willis D., Moore A.R., Frederick R., et al. Heme oxygenase. a novel target for the modulation of the inflammatory response. Nat Med 2 (1996) 87
19. Klahr S., and Morrissey J. Renal disease. the two faces of nitric oxide. Lab Invest 72 (1995) 1